ESBATECH
Founded in 1998 as a spin out of the University of Zurich, ESBATech is committed to becoming one of the leading developers of fully human antibody fragments for therapeutic applications. The company applies its proprietary, fully human single-chain antibody frameworks to generate product candidates against targets of clinical relevance. ESBATech is focused on delivering high concentrations of its therapeutic antibody fragments to the targeted sites, in combination with extremely low systemic load, in order to achieve low risk of systemic drug reactions using topical and local delivery.
ESBATECH
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
1998-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.esbatech.com
Total Employee:
51+
Status:
Active
Contact:
+41447334990
Email Addresses:
[email protected]
Total Funding:
72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon Gravatar Profiles OpenResty AdBlock Acceptable Ads Bodis DNS
Similar Organizations
Amrit Advanced Biotech
Amrit Advanced Biotech is a startup involved in genetics, telomeres health applications, and cancer mitigation.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
PDC Biotech
PDC Biotech develops novel compounds and therapeutics for the treatment of preterm labor and primary dysmenorrhea.
Current Advisors List
Current Employees Featured
Founder
Investors List
VI Partners
VI Partners investment in Series B - ESBATech
SV Health Investors
SV Health Investors investment in Series B - ESBATech
Novartis Venture Fund
Novartis Venture Fund investment in Series B - ESBATech
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - ESBATech
Clarus Ventures
Clarus Ventures investment in Series B - ESBATech
BioMedPartners
BioMedPartners investment in Series B - ESBATech
SV Health Investors
SV Health Investors investment in Series B - ESBATech
VI Partners
VI Partners investment in Series B - ESBATech
Novartis Venture Fund
Novartis Venture Fund investment in Series B - ESBATech
BioMedPartners
BioMedPartners investment in Series B - ESBATech
Official Site Inspections
http://www.esbatech.com
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago